Nateglinide: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Nateglinide. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Upper respiratory infection | 10.5% |
| Back pain | 4% |
| Flu symptoms | 3.6% |
| Dizziness | 3.6% |
| Arthropathy | 3.3% |
| Diarrhea | 3.2% |
| Accidental trauma | 2.9% |
| Bronchitis | 2.7% |
| Coughing | 2.4% |
| Hypoglycemia | 2.4% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
Nateglinide Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes mellitus.
Source: FDA labeling via NIH DailyMed (set b1cc7bfa…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.